Newt Gingrich also worries about comparative effectiveness decisionmaking, viz.
The problem is that, in the context of a government-run health care system, comparative effectiveness research becomes a way to find a cheaper, one-size-fits-all approach to medicine that will limit health care choices for patients.
But don’t just take my word for it. Congressional Democrats included $1.1 billion in the Stimulus Bill for CER. Report language explaining the bill noted that the treatments found to be “more expensive” as result of the research “will no longer be prescribed” and that “guidelines” should be developed to manage doctors.
Congressional Democrats also killed several amendments to the current health care bill that would have prevented CER from being used to ration care.
Posted using ShareThis
Thanks for agreeing with me, Newt. 😉